Xencor | XNCR - Cost Of Sales

Stock Price
11.61
Daily Change
0.79 7.30%
Monthly
-22.34%
Yearly
-31.87%
Q1 Forecast
11.72

Xencor reported $61.66M in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Alnylam Pharmaceuticals USD 200.15M 57.2M Sep/2025
Amgen USD 1.79B 128M Dec/2025
AstraZeneca USD 2.8B 328M Sep/2025
Biogen USD 810.1M 205.1M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Cytokinetics USD 112.55M 12.71M Jun/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
J&J USD 7.97B 689M Dec/2025
MacroGenics USD 44.3M 5.4M Sep/2025
Merck USD 3.32B 531M Dec/2025
Novartis USD 3.54B 217M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Regeneron Pharmaceuticals USD 584.6M 63M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Xencor USD 61.66M 50.95M Jun/2025